Sign In
Buy DNMR
$0.350
+0 (+0%)
At Close: Feb 20, 2026
Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace
08:00am, Tuesday, 31'st Dec 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of
NYSE to Commence Delisting Proceedings Against Danimer Scientific, Inc. (DNMR)
04:35pm, Monday, 30'th Dec 2024
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A c
Danimer Scientific Takes Action to Strengthen Capital Structure
04:15pm, Tuesday, 17'th Dec 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of
TerraNova Capital Equities announces three transactions totaling $45 Million
10:30am, Wednesday, 20'th Nov 2024
NEW YORK , Nov. 20, 2024 /PRNewswire/ -- TerraNova Capital Equities, inc. (TerraNova), a leading financial advisory firm, is pleased to announce that its Structure Finance Group acted as sole advisor
Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
10:07pm, Tuesday, 19'th Nov 2024
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2024 Earnings Conference Call November 19, 2024 10:00 AM ET Company Participants Rich Altice - Interim CEO Mike Hajost - CFO Conference Call Participants Unide
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates
10:40am, Tuesday, 19'th Nov 2024
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $8. This compares to loss of $15.60 per share a year ago.
Danimer Scientific Announces Third Quarter 2024 Results
08:30am, Tuesday, 19'th Nov 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of
Danimer Scientific Announces Release Date for Third Quarter 2024 Results
09:00am, Thursday, 14'th Nov 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production o
Danimer Scientific Announces Intention to Complete a Reverse Stock Split
04:30pm, Friday, 01'st Nov 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or “Company”), a leading, next-generation biotechnology company focused on the production of biomaterials, an
Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit
08:30am, Monday, 28'th Oct 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Company” or “Danimer Scientific”), a leading next generation bioplastics company focused on the development and produc
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biodegradable materials, and Ning
DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program
08:30am, Tuesday, 24'th Sep 2024
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer”), a leading, next-generation biotechnology company focused on the production of biomaterials, announces an award
What Makes Danimer Scientific (DNMR) a New Buy Stock
01:00pm, Wednesday, 14'th Aug 2024
Danimer Scientific (DNMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript
09:21am, Saturday, 10'th Aug 2024
Danimer Scientific, Inc (NYSE:DNMR ) Q2 2024 Results Conference Call August 8, 2024 4:30 PM ET Company Participants Blake Chamblee - Director of Financial Reporting Stephen Croskrey - Chairman and Chi
Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates
06:46pm, Thursday, 08'th Aug 2024
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.38 per share a year ago.
